CIAM
EBS icon

Caitong International Asset Management’s Emergent Biosolutions EBS Stock Holding History

Caitong International Asset Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,389
Closed -$15.2K – 2094
2025
Q2 		$15.2K Buy
2,389
+1,768
+285% +$10.1K 0.01% 576
2025
Q1 		$3.02K Buy
621
+450
+263% +$3.73K ﹤0.01% 1190
2024
Q4 		$1.64K Buy
+171
New +$1.57K ﹤0.01% 1207

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
OHA
Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Caitong International Asset Management's EBS Position: Q3 2025 in Review

Caitong International Asset Management sold out of Emergent Biosolutions (EBS) in Q3 2025, closing a stake of 2,389 shares — an estimated $15.2K sold.

Caitong International Asset Management first reported a position in EBS in Q4 2024 and held it in 3 quarters. The position peaked at $15.2K in Q2 2025. 169 funds tracked by Wall St. Rank hold EBS as of Q3 2025.

  • Caitong International Asset Management reported no remaining Emergent Biosolutions position as of Q3 2025 after selling out during the quarter.
  • Caitong International Asset Management sold 2,389 Emergent Biosolutions shares in Q3 2025, an estimated $15.2K.
  • Caitong International Asset Management first reported a position in Emergent Biosolutions in Q4 2024 and held it in 3 quarters.
  • Caitong International Asset Management's Emergent Biosolutions position peaked at $15.2K in Q2 2025.
  • 169 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2025.

Based on Caitong International Asset Management's 13F filing for Q3 2025, filed 19 Nov 2025.